Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorNational Cancer Institute, Naples
About this trial
This is multicentric, spontaneous, observational, retrospective and prospective study.
Eligibility criteria
Qualifiers
TNBC breast cancer patients, before any drug treatment
healthy women aged 25-60
Disqualifiers
donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, heart disease or drug treatment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov